MENU
+Compare
BCAB
Stock ticker: NASDAQ
AS OF
Aug 28, 10:49 AM (EDT)
Price
$0.44
Change
-$0.01 (-2.22%)
Capitalization
23.88M

BCAB BioAtla Forecast, Technical & Fundamental Analysis

BioAtla Inc is a clinical-stage biopharmaceutical company... Show more

BCAB
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
a Summary for BCAB with price predictions
Aug 26, 2025

BCAB sees its Stochastic Oscillator recovers from oversold territory

On August 26, 2025, the Stochastic Oscillator for BCAB moved out of oversold territory and this could be a bullish sign for the stock. Traders may want to buy the stock or buy call options. Tickeron's A.I.dvisor looked at 62 instances where the indicator left the oversold zone. In of the 62 cases the stock moved higher in the following days. This puts the odds of a move higher at over .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The RSI Oscillator points to a transition from a downward trend to an upward trend -- in cases where BCAB's RSI Oscillator exited the oversold zone, of 44 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .

The Momentum Indicator moved above the 0 level on August 26, 2025. You may want to consider a long position or call options on BCAB as a result. In of 76 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

The Moving Average Convergence Divergence (MACD) for BCAB just turned positive on August 06, 2025. Looking at past instances where BCAB's MACD turned positive, the stock continued to rise in of 39 cases over the following month. The odds of a continued upward trend are .

BCAB moved above its 50-day moving average on August 26, 2025 date and that indicates a change from a downward trend to an upward trend.

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where BCAB advanced for three days, in of 222 cases, the price rose further within the following month. The odds of a continued upward trend are .

Bearish Trend Analysis

Following a 3-day decline, the stock is projected to fall further. Considering past instances where BCAB declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

BCAB broke above its upper Bollinger Band on August 26, 2025. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

The Aroon Indicator for BCAB entered a downward trend on July 31, 2025. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating fairly steady price growth. BCAB’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (37.736) is normal, around the industry mean (19.605). P/E Ratio (0.000) is within average values for comparable stocks, (54.592). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (2.646). Dividend Yield (0.000) settles around the average of (0.043) among similar stocks. P/S Ratio (2.181) is also within normal values, averaging (305.338).

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. BCAB’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 95, placing this stock worse than average.

View a ticker or compare two or three
BCAB
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I. Advisor
published Earnings

BCAB is expected to report earnings to fall 14.59% to -27 cents per share on November 05

BioAtla BCAB Stock Earnings Reports
Q3'25
Est.
$-0.27
Q2'25
Missed
by $0.06
Q1'25
Beat
by $0.13
Q4'24
Beat
by $0.08
Q3'24
Beat
by $0.19
The last earnings report on August 07 showed earnings per share of -31 cents, missing the estimate of -25 cents. With 1.64M shares outstanding, the current market capitalization sits at 23.88M.
A.I. Advisor
published General Information

General Information

Industry Biotechnology

Profile
Fundamentals
Details
Industry
N/A
Address
11085 Torreyana Road
Phone
+1 858 558-0708
Employees
65
Web
https://www.bioatla.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
NDAQ94.84-0.06
-0.06%
Nasdaq
APOG44.31-0.03
-0.07%
Apogee Enterprises
CRK15.77-0.10
-0.63%
Comstock Resources
LPTH4.80-0.12
-2.44%
LightPath Technologies
CING4.18-0.12
-2.79%
Cingulate Inc

BCAB and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, BCAB has been loosely correlated with AXON. These tickers have moved in lockstep 41% of the time. This A.I.-generated data suggests there is some statistical probability that if BCAB jumps, then AXON could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BCAB
1D Price
Change %
BCAB100%
+9.89%
AXON - BCAB
41%
Loosely correlated
+0.09%
KYMR - BCAB
39%
Loosely correlated
-3.67%
VCYT - BCAB
38%
Loosely correlated
-1.58%
CTMX - BCAB
38%
Loosely correlated
+1.97%
DNLI - BCAB
36%
Loosely correlated
+0.32%
More